Prognostic factors in survival of bladder cancer

Cancer

Volumn 70, Issue 4, 1992, Pages 799-807

  Lopez‐Beltran, Antonio ^a,b   Croghan, Gary A ^a   Crogkan, Ivana ^a   Huben, Robert P ^a   Mettlin, Curtis ^a   Gaeta, John F ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

bladder; cancer; DNA flow cytometry; immunohistochemistry; prognosis; smoking; tumor markers

Indexed keywords

BLOOD GROUP A ANTIGEN; CELL MARKER; DNA; PROTEIN P21; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

ABO BLOOD-GROUP SYSTEM; AGED; ANTIGENS, NEOPLASM; BLADDER NEOPLASMS; CA-15-3 ANTIGEN; DNA, NEOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; ISOANTIGENS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; NEOPLASM STAGING; ONCOGENE PROTEIN P21(RAS); PLOIDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SMOKING; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0026748198     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19920815)70:4<799::AID-CNCR2820700414>3.0.CO;2-F     Document Type: Article

References (34)

1. Cancer statistics, 1990
2. The prevalence of cancer: estimates based on the Connecticut tumor registry
3. Concepts in causality: chemically induced urinary bladder cancer
4. Risk assessment of a cohort exposed to aromatic amines
5. Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharine consumption
6. The epidemiology of bladder cancer: a second look
7. Occupation, tobacco use, coffee, and bladder cancer in the county of Mataró (Spain)
8. Smoking and bladder cancer: the modifying effect of cigarettes on other factors
9. Bladder cancer in relation to cigarette smoking
10. Further cytological and histological studies of bladder lesions in workers exposed to paraaminodiphenyl: progress report
11. T‐zone histiocytes and recurrence of papillary urothelial bladder carcinoma
12. Superficial bladder tumors: aspects of clinical progression
13. Prognostic indices in transitional cell carcinoma of the bladder: a review
14. An immunohistochemical evaluation of urinary bladder cytology using monoclonal antibodies
15. Detection of urothelial Lewis antigens with monoclonal antibodies
16. Blood group isoantigens ABO(H) in transitional carcinoma of the bladder: a clinicopathological study
17. T‐Antigen: a prognostic indicator of high recurrence index in transitional carcinoma of the bladder
18. Prognostic significance of ABH antigenicity of mucosal biopsies in superficial bladder cancer
19. Expression of blood group precursor T‐antigen as a prognostic marker for human bladder cancer treated by Bacilus Calmette‐Guering and lnter‐leukin‐2
20. H‐ras oncogene p‐21 expression is increased in premalignant lesions and high grade bladder carcinoma
21. Immunocytochemical demonstration of p‐21‐ras in normal and transitional cell carcinoma urothelium
22. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids
23. Phenotyping of 76 human bladder tumors with a panel of monoclonal antibodies: correlation between pathology, surface immunofluorescence and DNA content
24. Tumors of the urinary bladder
25. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques
26. Statistical aspects of analysis of data from retrospective studies of Disease
27. The relation of ras oncogene product p21 expression to clinicopathological status criteria and clinical outcome in squamous cell head and neck cancer
28. Epithelial membrane antigen as an immunohistochemical marker for transitional cell carcinoma of urinary bladder
29. Expression of p21‐ras in normal and malignant tissues: lack of association with proliferation and malignancy